Urology therapeutics Market Research Reports

"...... the therapeutics under development for Tuberous Sclerosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological......"

"...... > The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......"

"...... Bulbar Muscular Atrophy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Kennedy's Disease (Spinal and Bulbar Muscular Atrophy), complete with analysis by Stage of Development,......"

"...... mprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......"

"...... r /> The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) a......"

"...... therapeutics under development for Tay-Sachs Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Act......"

"...... em And Sex Hormones pipeline landscape. The report provides comprehensive information on the therapeutics under development for Genito Urinary System And Sex Hormones, complete with analysis by Stage of Development, Drug Target, Mechanis......"

"...... des comprehensive information on the therapeutics under development for Chronic Granulomatous Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report......"

"...... e I (Arginosuccinate Synthetase Deficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Citrullinemia Type I (Arginosuccinate Synthetase Deficiency), complete with analysis ......"

"...... evelopment for Cystinuria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its......"